Why medication is a different cost problem from surgery
A knee replacement or a dental crown is a single event. You travel, you are treated, you recover and the cost is mostly behind you. Insulin and GLP-1 drugs such as semaglutide and tirzepatide are the opposite: they are used continuously, often for years, and a gap in supply has clinical consequences.
That changes the question. The useful comparison is not "how much is one box abroad versus at home" but "what does it cost me, over twelve months, to stay reliably supplied with a genuine product that my doctor is monitoring". Once you frame it that way, several costs appear that a pharmacy price tag never shows.
The US import rule to understand first
For Americans, the starting point is the FDA's position on personal importation. The FDA's personal importation page (2025) says that in most circumstances it is illegal for individuals to bring drugs into the US for personal use, and that the agency cannot vouch for the safety of medicine bought during trips abroad.
The FDA describes an enforcement-discretion approach that its staff may apply to a prescription drug for a serious condition when all of the following are true:
- Effective treatment may not be available in the US.
- The product is not commercialized or promoted to people living in the US.
- The product does not represent an unreasonable risk.
- You affirm in writing that it is for personal use.
- The quantity is generally no more than a three-month supply.
- You can give the name and address of the US-licensed doctor responsible for your treatment, or show the product continues a treatment begun abroad.
Two points matter for cost planning. First, this is discretion, not an entitlement; a plan that depends on it can fail at the border. Second, insulin and the major GLP-1 drugs are sold in the US, which makes the first condition difficult to meet. A strategy of "fly out every quarter and bring back three months" therefore rests on an assumption the FDA itself does not guarantee.
Counterfeit, compounded and poorly stored products
GLP-1 medicines have attracted fakes. In its page on concerns with unapproved GLP-1 drugs, the FDA reports counterfeit Ozempic found in the US, warns that counterfeits may contain the wrong amount of active ingredient, none at all or harmful substances, and says it had received more than 392 adverse-event reports involving compounded semaglutide and more than 215 involving compounded tirzepatide as of November 30, 2024. It also warns against products sold "for research purposes" and urges buying only from state-licensed pharmacies.
The risk is not confined to the US. The CDC Yellow Book (2026) notes that drugs abroad may not face the same regulatory oversight, and that some may be counterfeit or ineffective because of expiry, contamination or poor storage.
Storage is the quiet issue. Insulin and injectable GLP-1 pens are temperature-sensitive products that are normally kept refrigerated until first use; check the storage instructions in the package leaflet. A pen that sat in a hot delivery van or a hotel room without refrigeration may look identical to a good one. When you buy abroad, you usually cannot see the cold chain behind the counter, and you then have to protect it yourself on the flight and at your destination.
Four ways people handle chronic medication around travel
| Pattern | What it involves | Main cost and risk points |
|---|---|---|
| Carry your home supply | Fill your usual prescription before leaving and take enough for the whole trip | Lowest risk. The CDC advises bringing enough of all regular medications to last the entire trip. Costs are a travel cooler and your normal copay. |
| Buy locally for use during the stay | Purchase at a destination pharmacy for the weeks you are there | Moderate risk: brand names, strengths and pen devices can differ, so units and doses must be checked against your prescription. |
| Buy abroad to bring home | Purchase a supply abroad specifically to use later in the US | Highest uncertainty: depends on FDA discretion, the three-month guideline and documentation; product quality is hard to verify. |
| Live abroad and switch care | Establish a local prescriber and pharmacy in the new country | Workable for long-term residents, but it means new clinic fees, local lab monitoring and a full handover of records. |
Pricing a year of supply, not a single pen
A fair annual comparison has more rows than most people expect. Build it like this:
- Drug cost: the price per pen, vial or box, times the number you need in a year at your actual dose.
- Prescriber cost: visits to whoever is writing the prescription, at home, abroad or both.
- Monitoring: lab work such as HbA1c checks for diabetes, and any dose-adjustment visits.
- Supply trips: if purchases depend on travel, the flights, nights and time off for each restocking trip.
- Storage: insulated travel cases, cooling packs, and replacement supply if a batch is spoiled.
- Gap risk: what it would cost to cover a missed shipment or a confiscation at short notice, usually at your home cash price.
Illustrative example (hypothetical figures): imagine a medication that costs you $300 a month at home through your plan and $180 a month abroad. The visible saving is $1,440 a year. If staying supplied requires two extra trips a year at $700 each, plus one emergency refill at full home price, the saving is gone. If, on the other hand, you already live part of the year in the destination and travel there anyway, the same price difference may be real. The arithmetic depends on whether the trips would happen without the medication.
Insulin and GLP-1s are not the same problem
Insulin
The cost of an insulin interruption is clinical before it is financial, which is why supply continuity matters more than unit price. Formulations, concentrations and pen devices are not identical worldwide, so a product with a familiar molecule name may still require a different dose calculation or different needles. Any switch should be agreed with the clinician who manages your diabetes, not improvised at a pharmacy counter.
GLP-1 medications
For semaglutide and tirzepatide, the bigger issue is authenticity and dosing. The FDA's warnings about counterfeits, compounded versions given at doses outside the approved label, and "research use" products apply directly to anyone buying outside the normal pharmacy system. A suspiciously low price is a reason to ask more questions, not fewer.
Before you buy any chronic medication abroad
Bring your prescription and a letter from your doctor listing the generic name, strength and dose. Buy only from a licensed pharmacy, keep the receipt and packaging, check expiry dates, and ask how the product has been stored. If the plan involves bringing medicine back to the US, read the FDA's personal importation guidance before you travel, not at the airport.
Where this fits with the rest of your care
For most people, international pharmacy prices are a supplement to a stable home arrangement rather than a replacement for it. A doctor who sees your lab results, adjusts your dose and can prescribe locally is worth more over a year than any single discount. If you are weighing Colombia specifically, our side-by-side look at prescription drug costs in the USA and Colombia covers the price picture, while chronic disease management abroad looks at the visits and monitoring around the medicine.
Insurance is the last piece. Many US plans may not reimburse a pharmacy purchase made abroad, and travel-medical policies are designed for emergencies rather than routine refills. Our guide to what insurance covers versus out-of-pocket abroad explains where those lines usually fall.
The Takeaway
Compare the cost of a year of genuine, uninterrupted, monitored supply. If the plan depends on regular trips, FDA discretion at the border or a seller you cannot verify, the cheaper pen is not the cheaper option.
Frequently asked questions
Can I bring insulin or a GLP-1 drug back to the US from abroad?
The FDA says personal importation of drugs is generally illegal, although its staff may use discretion for a serious condition when several conditions are met, including a supply of generally no more than three months, a written personal-use statement and the details of your US doctor. Because these drugs are sold in the US, do not assume that discretion will apply.
Is a GLP-1 medicine bought abroad likely to be fake?
You cannot assume either way. The FDA has found counterfeit Ozempic in the US and warns about unapproved online and "research use" products, and the CDC notes that drugs abroad may be counterfeit or poorly stored. Buy only from a licensed pharmacy, keep the packaging and receipt, and check the expiry date.
How much medication should I take with me on a trip?
The CDC Yellow Book advises bringing enough of all your regular medications to last the entire trip. Agree any extra margin for delays with your prescriber, and carry your prescription and a doctor's letter listing the generic names and doses.
Will my US insurance reimburse insulin I buy abroad?
It may not. Check with your plan before you buy, and remember that travel-medical policies are generally designed for emergencies rather than routine refills.
Is insulin the same in other countries?
The active molecule may be the same, but concentrations, brand names and pen devices can differ between countries. Confirm units and dosing with the clinician who manages your diabetes before switching to a product bought abroad.